Evidence map›Paper›PMID 24323416›Full record

ReviewTranslational stroke research2013

Mitochondrial dysfunction and NAD(+) metabolism alterations in the pathophysiology of acute brain injury.

Katrina Owens, Ji H Park, Rosemary Schuh, Tibor Kristian

Abstract readReview
PubMed Publisher
In one paragraph

Review in Translational stroke research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Exploration of the Molecular Mechanisms Underlying the Anti-Photoaging Effect ofFrontiers in cellular and infection microbiology · 2022
    Article
  8. Article
  9. Review
  10. Role of NADBrain sciences · 2020
    Review
  11. Article
  12. Article
  13. Article
  14. Mitochondrial Protection by PARP Inhibition.International journal of molecular sciences · 2020
    Review
  15. NADExperimental neurology · 2020
    Review
  16. Review
  17. Interplay between NADBiochimica et biophysica acta. Molecular basis of disease · 2019
    Review
  18. Article
  19. Role of mitochondrial calcium uniporter-mediated CaJournal of cellular and molecular medicine · 2019
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Katrina OwensVeterans Affairs Maryland Health Care System, 10 North Greene Street, Baltimore, MD, 21201, USA.
Ji H Park
Rosemary Schuh
Tibor Kristian
VA Maryland Health Care System · USUniversity of Maryland, Baltimore · US

Funding

Nudix hydrolases and mitochondrial dynamics in acute neurodegenerative diseaseI01BX000917 · VA · BALTIMORE VA MEDICAL CENTER · PI KRISTIAN, TIBOR · 2011 to 2019
–
6 · The paper itself

Abstract

Mitochondrial dysfunction is commonly believed to be one of the major players in mechanisms of brain injury. For several decades, pathologic mitochondrial calcium overload and associated opening of the mitochondrial permeability transition (MPT) pore were considered a detrimental factor causing mitochondrial damage and bioenergetics failure. Mitochondrial and cellular bioenergetic metabolism depends on the enzymatic reactions that require NAD(+) or its reduced form NADH as cofactors. Recently, it was shown that NAD(+) also has an important function as a substrate for several NAD(+) glycohydrolases whose overactivation can contribute to cell death mechanisms. Furthermore, downstream metabolites of NAD(+) catabolism can also adversely affect cell viability. In contrast to the negative effects of NAD(+)-catabolizing enzymes, enzymes that constitute the NAD(+) biosynthesis pathway possess neuroprotective properties. In the first part of this review, we discuss the role of MPT in acute brain injury and its role in mitochondrial NAD(+) metabolism. Next, we focus on individual NAD(+) glycohydrolases, both cytosolic and mitochondrial, and their role in NAD(+) catabolism and brain damage. Finally, we discuss the potential effects of downstream products of NAD(+) degradation and associated enzymes as well as the role of NAD(+) resynthesis enzymes as potential therapeutic targets.

Indexed as

ADP-ribosyl Cyclase 1Agouti-Related ProteinAnimalsBrain InjuriesHumansMiceMitochondriaNADPoly(ADP-ribose) PolymerasesADP-ribosyl Cyclase 1Agouti-Related ProteinAGRP protein, humanNADPoly(ADP-ribose) Polymerases

Identifiers

PMID24323416
OpenAlexW1992468844

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.